Chiron, Murex, Ortho Diagnostic Systems Inc. diagnostics/imaging, infectious diseases/aids news

The companies reached a worldwide agreement covering tests for hepatitis C virus (HCV), which will end all litigation between the companies.

MURXF receives a worldwide license to sell HCV serotyping tests and other HCV tests in selected regions, excluding North America, European Economic Community members and Japan. CHIR and partner Ortho receive rights to MURXF's Sample Addition Monitor (SAM) technology, as well as an option to sell MURXF's HCV serotyping test. SAM, combined with color-coated reagents, provides color changes at each step to ensure that samples have been added and testing procedures have been done correctly. ...